Oxford Nanopore Technologies (ONT.L) Stock Analysis & Winston Score

Oxford Nanopore Technologies makes machines that read DNA and RNA. Scientists use these devices to study genes, track disease outbreaks, and identify viruses. The company is based in Oxford, UK, and is one of the few firms in the world that has commercialized nanopore-based sequencing technology at scale. The company sells its sequencing devices and the consumable cartridges that go with them, so it earns money each time a customer runs a new experiment. It sells to research labs, hospitals, and public health agencies across Europe, North America, and Asia. Its main competitive edge is that its devices are portable and can produce results quickly, unlike larger traditional sequencing machines. However, the company is still losing significant money — its operating margin is deeply negative — and the key risk is whether it can grow revenue fast enough to reach profitability before needing to raise more cash.